HealthDay News — For patients with lentigo maligna (LM) in-situ melanoma, topical imiquimod has a pathological complete regression (pCR) rate of 37%, according to a study published online October 6 in ...

Please provide your email address to receive an email when new articles are posted on . Imiquimod treatment for 16 weeks exhibited a 90% tumor clearance rate in persistent MMIS at margins of resection ...

Imiquimod is a generic prescription medication. The Food and Drug Administration (FDA) has approved it to treat: As with all medications, the cost of imiquimod can vary. Factors that may affect the ...

Although all authors completed the disclosure declaration, the following author(s) indicated a financial or other interest that is relevant to the subject matter under consideration in this article.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Five years after treatment, results showed a freedom ...

Our analysis of currently available data regarding imiquimod (Aldara) is that it can likely be used in renal transplant recipients without incurring a probable risk of acute rejection. However, ...

Calcipotriol plus 5-FU immunotherapy activates Th2 immunity, releasing IL-24 cytokines to suppress skin cancer development in patients with actinic keratosis. The combination therapy significantly ...